INDOMETHACIN TREATMENT IN OSTEOARTHRITIS OF THE HIP-JOINT - DOES THE TREATMENT INTERFERE WITH THE NATURAL COURSE OF THE DISEASE

被引：81

作者：

RONNINGEN, H ^{[1
]}

LANGELAND, N ^{[1
]}

机构：

[1] UNIV OSLO, SOPHIES MINDE ORTHOPAED HOSP, OSLO, NORWAY

来源：

ACTA ORTHOPAEDICA SCANDINAVICA | 1979年 / 50卷 / 02期

关键词：

Hip joint; Indomethacin; Osteoarthritis;

D O I：

10.3109/17453677908989752

中图分类号：

R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];

学科分类号：

摘要：

The course of osteoarthritis in 294 hips of 186 patients was evaluated by examining their radiographs. the development of the disease in patients treated with indomethacin was compared with that in a control material. In the indomethacin group the disease progressed more frequently and in one parameter the progress was more severe. the results support previous reports indicating that indomethacin might have a deleterious effect on osteoarthritic hip joints. Some possible explanations for this adverse effect of indomethacin treatment are discussed. © 1979 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.

引用

页码：169 / 174

页数：6

共 50 条

[31] Surgical options and outcomes for treatment of osteoarthritis of the scaphotrapeziotrapezoidal joint
Bellemere, Philippe
Ardouin, Ludovic
JOURNAL OF HAND SURGERY-EUROPEAN VOLUME, 2025, 50 (01) : 58 - 67
[32] Drug delivery systems for treatment of temporomandibular joint osteoarthritis
Huang, Xinqi
Pan, Xuefeng
Xiong, Xiner
Zhao, Zhihe
Cen, Xiao
FRONTIERS IN PHARMACOLOGY, 2022, 13
[33] Is behavioral graded activity effective for the treatment of hip and knee osteoarthritis?
Mazzuca, Steven A.
NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (06): : 322 - 323
[34] Development of the "Treatment beliefs in knee and hip OsteoArthritis (TOA)" questionnaire
Selten, Ellen M. H.
Vriezekolk, Johanna E.
Schers, Henk J.
Nijhof, Marc W.
van der Laan, Willemijn H.
van der Meulen-Dilling, Roelien G.
Geenen, Rinie
van den Ende, Cornelia H. M.
BMC MUSCULOSKELETAL DISORDERS, 2017, 18
[35] Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip
Kivitz, AJ
Moskowitz, RW
Woods, E
Hubbard, RC
Verburg, KM
Lefkowith, JB
Geis, GS
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2001, 29 (06) : 467 - 479
[36] Development of the “Treatment beliefs in knee and hip OsteoArthritis (TOA)” questionnaire
Ellen M. H. Selten
Johanna E. Vriezekolk
Henk J. Schers
Marc W. Nijhof
Willemijn H. van der Laan
Roelien G. van der Meulen-Dilling
Rinie Geenen
Cornelia H. M. van den Ende
BMC Musculoskeletal Disorders, 18
[37] Incidence, prevalence, natural course and prognosis of patellofemoral osteoarthritis: the Cohort Hip and Cohort Knee study
Lankhorst, N. E.
Damen, J.
Oei, E. H.
Verhaar, J. A. N.
Kloppenburg, M.
Bierma-Zeinstra, S. M. A.
van Middelkoop, M.
OSTEOARTHRITIS AND CARTILAGE, 2017, 25 (05) : 647 - 653
[38] Efficacy of disease-modifying osteoarthritis drugs in the treatment of osteoarthritis
Park, Junyong
Lee, Sung Won
JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2024, 67 (10): : 641 - 648
[39] Treatment of primary hip osteoarthritis for the primary care physician and the indications for total hip arthroplasty
Levine, Mathew E.
Nace, James
Kapadia, Bhaveen H.
Issa, Kimona
Banerjee, Samik
Cherian, Jeffrey J.
Mont, Michael A.
Journal of Long-Term Effects of Medical Implants, 2013, 23 (04) : 323 - 330
[40] Does Hip Arthroscopy Have a Role in the Treatment of Developmental Hip Dysplasia?
Kirsch, Jacob M.
Khan, Moin
Bedi, Asheesh
JOURNAL OF ARTHROPLASTY, 2017, 32 (09) : S28 - S31

← 1 2 3 4 5 →